Atlas FDA

The Spanner Temporary Prostatic Stent

FDA premarket approval P060010/S013 · decided 2022-10-07

Approval details

PMA number
P060010
Supplement
S013
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
The Spanner Temporary Prostatic Stent
Generic name
Stent, urethral, prostatic, semi-permanent
Applicant
Srs Medical
Date received
2020-06-22
Decision date
2022-10-07
Days to decision
837 days
Decision code
APPR
Product code
NZC
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
North Billerica, MA
Statement
Approval for the Spanner Prostatic Stent. The device is intended for temporary use (up to 30 days) to maintain urine flow and allow voluntary urination for patients who are not candidates for pharmacologic, minimally invasive or surgical treatment of the prostate.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
CT3000Pro (K212830)Srs Medical2021-12-21